Karat Packaging Reports Fourth Quarter and Full Year 2023 Financial Results
CHINO, Calif., March 14, 2024 (GLOBE NEWSWIRE) — Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor […]
TSX News -
TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results
Full year 2023 record Net Revenue of $317.3 million, an increase of 28.0% year-over-year Full year 2023 Gross Profit margin […]
Getty Images Reports Fourth Quarter and Full Year 2023 Results
NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) — Getty Images Holdings, Inc. “Getty Images” or the “Company”) (NYSE: GETY), a […]
Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial Results
Fiscal year 2023 net product sales from prescriptions totaled approximately $5.2M, a 107% increase from 2022 Company projects $14M in […]
Kandi Technologies Reports 2023 Financial Results
JINHUA, China, March 14, 2024 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (the “Company”, “we” or “Kandi”) (NASDAQ GS: KNDI), […]
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
PURCHASE, N.Y., March 14, 2024 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc. (“Cognition,” the “Company” or “We”) (Nasdaq: CGTX), a clinical […]
Rigetti Computing Reports Fourth Quarter and Full Year 2023 Results
Deployed the 84-qubit Ankaa™-2 quantum computer, with a 2.5X improvement in error performance compared to the Company’s previous QPUs and […]
Oxford to Release Fourth Quarter Fiscal 2023 Results on March 28, 2024
ATLANTA, March 14, 2024 (GLOBE NEWSWIRE) — Oxford Industries, Inc. (NYSE: OXM) today announced that it plans to release its […]
EverCommerce Announces Fourth Quarter and Full Year 2023 Financial Results
DENVER, March 14, 2024 (GLOBE NEWSWIRE) — EverCommerce Inc. (“EverCommerce” or the “Company”) (NASDAQ: EVCM), a leading service commerce platform, […]
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Cema-cel Pivotal ALPHA3 First Line (1L) Consolidation Trial in Large B-Cell Lymphoma (LBCL): Start-Up Activities Underway; Enrollment to Begin Mid-2024 […]
